Kontrol og behandling af hiv-associeret lipodystrofisyndrom og relaterede metaboliske komplikationer
Sammanfattning
Following the introduction of highly active anti-retroviral therapy (HAART) in HIV patients, an increase in metabolic complications, including HIV-associated lipodystrophy syndrome has been observed. A panel selected by the International AIDS Society-USA has recently developed recommendations for assessment, monitoring and treatment of these complications. This article presents guidelines based on the society's recommendations and newly available data.